Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in Mice
Author Information
Author(s): Ian M. Rosenthal, Ming Zhang, Kathy N. Williams, Charles A. Peloquin, Sandeep Tyagi, Andrew A. Vernon, William R. Bishai, Richard E. Chaisson, Jacques H. Grosset, Eric L. Nuermberger
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
Can existing drugs be used more effectively to shorten the treatment duration for tuberculosis?
Conclusion
Daily and thrice-weekly administration of rifapentine and moxifloxacin can cure tuberculosis in mice in three months or less.
Supporting Evidence
- Mice treated with rifapentine and moxifloxacin had negative lung cultures after 2 months.
- Standard treatment required 6 months to achieve similar results.
- No relapses were observed in mice treated with the new regimen after 3 months.
Takeaway
Researchers found that giving mice a combination of two drugs every day or three times a week can cure tuberculosis much faster than the usual treatment.
Methodology
Mice infected with tuberculosis were treated with different drug regimens, and their lung cultures were monitored for bacterial growth.
Potential Biases
Potential bias in extrapolating results from mice to humans.
Limitations
Results are based on a murine model, which may not fully predict human responses.
Participant Demographics
Mice (BALB/c strain) were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website